Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • naked_finger naked_finger Jul 31, 2013 12:38 AM Flag

    Synta Pharmaceuticals Corp. Given New $20.00 Price Target at Roth Capital (SNTA)

    Equities research analysts at Roth Capital lifted their price target on shares of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) from $18.00 to $20.00 in a research note issued to investors on Tuesday,

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The firm currently has a “buy” rating on the stock. Roth Capital’s target price indicates a potential upside of 193.69% from the company’s current price.

      Several other analysts have also recently commented on the stock. Analysts at JMP Securities upgraded shares of Synta Pharmaceuticals Corp. from a “market perform” rating to an “outperform” rating in a research note to investors on Tuesday, July 16th. They now have a $11.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Synta Pharmaceuticals Corp. in a research note to investors on Tuesday, July 2nd. They now have a $22.00 price target on the stock. Finally, analysts at MLV Capital cut their price target on shares of Synta Pharmaceuticals Corp. from $18.50 to $16.00 in a research note to investors on Thursday, June 6th. They now have a “buy” rating on the stock.

      Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Synta Pharmaceuticals Corp. has an average rating of “Buy” and a consensus price target of $16.20.

    • Shorts, Soil ur brown pants. Haha

 
SNTA
0.3430.000(0.00%)Jul 22 4:00 PMEDT